(Q80587777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Shelly Lensing

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Yinmei Zhou

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

John T Sandlund

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bassem I Razzouk

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Raul C Ribeiro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ching-Hon Pui

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 October 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1677-1684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

Acute lymphoblastic leukemia

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Results of Therapy for Acute Lymphoblastic Leukemia in Black and White Children

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Treatment of childhood acute myelogenous leukemia with an intensive regimen (AML-87) that individualizes etoposide and cytarabine dosages: short- and long-term effects.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20532

7 January 2021

Identifiers

DOI

10.1002/CNCR.20532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15378506%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference